These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15914559)

  • 1. Inhibitors of XIAP sensitize CD40-activated chronic lymphocytic leukemia cells to CD95-mediated apoptosis.
    Kater AP; Dicker F; Mangiola M; Welsh K; Houghten R; Ostresh J; Nefzi A; Reed JC; Pinilla C; Kipps TJ
    Blood; 2005 Sep; 106(5):1742-8. PubMed ID: 15914559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia.
    Chu P; Deforce D; Pedersen IM; Kim Y; Kitada S; Reed JC; Kipps TJ
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3854-9. PubMed ID: 11891278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD154 induces p73 to overcome the resistance to apoptosis of chronic lymphocytic leukemia cells lacking functional p53.
    Dicker F; Kater AP; Prada CE; Fukuda T; Castro JE; Sun G; Wang JY; Kipps TJ
    Blood; 2006 Nov; 108(10):3450-7. PubMed ID: 16741250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of the CD95 receptor and defect CD40-mediated signal transduction in B-chronic lymphocytic leukemia cells.
    Laytragoon-Lewin N; Duhony E; Bai XF; Mellstedt H
    Eur J Haematol; 1998 Oct; 61(4):266-71. PubMed ID: 9820634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas-ligand (CD178) and TRAIL synergistically induce apoptosis of CD40-activated chronic lymphocytic leukemia B cells.
    Dicker F; Kater AP; Fukuda T; Kipps TJ
    Blood; 2005 Apr; 105(8):3193-8. PubMed ID: 15339846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD154 gene therapy for human B-cell malignancies.
    Messmer D; Kipps TJ
    Ann N Y Acad Sci; 2005 Dec; 1062():51-60. PubMed ID: 16461788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40 activation does not protect chronic lymphocytic leukemia B cells from apoptosis induced by cytotoxic T lymphocytes.
    Chu P; Wierda WG; Kipps TJ
    Blood; 2000 Jun; 95(12):3853-8. PubMed ID: 10845920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia.
    Kitada S; Zapata JM; Andreeff M; Reed JC
    Br J Haematol; 1999 Sep; 106(4):995-1004. PubMed ID: 10520003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I study of immune gene therapy for patients with CLL using a membrane-stable, humanized CD154.
    Wierda WG; Castro JE; Aguillon R; Sampath D; Jalayer A; McMannis J; Prussak CE; Keating M; Kipps TJ
    Leukemia; 2010 Nov; 24(11):1893-900. PubMed ID: 20882050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies.
    Wang D; Freeman GJ; Levine H; Ritz J; Robertson MJ
    Br J Haematol; 1997 May; 97(2):409-17. PubMed ID: 9163608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to CD95-mediated apoptosis of CD40-activated chronic lymphocytic leukemia B cells is not related to lack of DISC molecules expression.
    de Totero D; Montera M; Rosso O; Clavio M; Balleari E; Foa R; Gobbi M
    Hematol J; 2004; 5(2):152-60. PubMed ID: 15048066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40 stimulation of B-cell chronic lymphocytic leukaemia cells enhances the anti-apoptotic profile, but also Bid expression and cells remain susceptible to autologous cytotoxic T-lymphocyte attack.
    Kater AP; Evers LM; Remmerswaal EB; Jaspers A; Oosterwijk MF; van Lier RA; van Oers MH; Eldering E
    Br J Haematol; 2004 Nov; 127(4):404-15. PubMed ID: 15521917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells.
    Furman RR; Asgary Z; Mascarenhas JO; Liou HC; Schattner EJ
    J Immunol; 2000 Feb; 164(4):2200-6. PubMed ID: 10657675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid CD40-mediated rescue from CD95-induced apoptosis requires TNFR-associated factor-6 and PI3K.
    Benson RJ; Hostager BS; Bishop GA
    Eur J Immunol; 2006 Sep; 36(9):2535-43. PubMed ID: 16897814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel paradigm to trigger apoptosis in chronic lymphocytic leukemia.
    Loeder S; Zenz T; Schnaiter A; Mertens D; Winkler D; Döhner H; Debatin KM; Stilgenbauer S; Fulda S
    Cancer Res; 2009 Dec; 69(23):8977-86. PubMed ID: 19920200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia.
    Wierda WG; Cantwell MJ; Woods SJ; Rassenti LZ; Prussak CE; Kipps TJ
    Blood; 2000 Nov; 96(9):2917-24. PubMed ID: 11049967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CM1 ligation initiates apoptosis in a caspase 8-dependent manner in Ramos cells and in a mitochondria-controlled manner in Raji cells.
    Kim D; Hur DY; Kim YS; Lee K; Lee Y; Cho D; Kang JS; Kim YI; Hahm E; Yang Y; Yoon S; Kim S; Lee WB; Park HY; Kim YB; Hwang YI; Chang KY; Lee WJ
    Hum Immunol; 2002 Jul; 63(7):576-87. PubMed ID: 12072193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway.
    Lapalombella R; Andritsos L; Liu Q; May SE; Browning R; Pham LV; Blum KA; Blum W; Ramanunni A; Raymond CA; Smith LL; Lehman A; Mo X; Jarjoura D; Chen CS; Ford R; Rader C; Muthusamy N; Johnson AJ; Byrd JC
    Blood; 2010 Apr; 115(13):2619-29. PubMed ID: 19965642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells.
    Romano C; De Fanis U; Sellitto A; Dalla Mora L; Chiurazzi F; Giunta R; Rotoli B; Lucivero G
    Leuk Lymphoma; 2003 Nov; 44(11):1963-71. PubMed ID: 14738151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD40 ligand in CLL pathogenesis and therapy.
    Schattner EJ
    Leuk Lymphoma; 2000 May; 37(5-6):461-72. PubMed ID: 11042507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.